.png){kind=icon}
.png){kind=icon}
Return
Engineering Epigenome Editing Tools: Current Progress and Future Perspectives
.png){kind=icon}
OA
AI
DOI：10.1016/j.cobme.2026.100662.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Epigenome editing, the site-specific rewriting of chromatin modifications, provides a powerful approach to modulate gene regulation in basic research, biotechnology and pre-clinical settings. Synthetic epigenome editors (EpiEditors) contain a programmable DNA-binding module (CRISPR/dCas systems, zinc finger, and TALE proteins), combined with effector modules derived from chromatin-modifying enzymes (such as DNA methyltransferases or TET dioxygenases) or recruitment domains (such as KRAB). Substantial progress has been made in recent years in improving the specificity, stability, and functional robustness of epigenome editing technologies. Advances include optimized effector domains with reduced off-target activity, toxicity and size, expanded CRISPR/Cas toolkits, combinatorial and modular editor designs, and increasingly efficient delivery strategies based on viral vectors, lipid nanoparticles, virus-like particles, and engineered exosomes. Epigenome editing allows to dissect causal relationships between chromatin states and gene regulation, revealing context-dependent and combinatorial effects of epigenetic modifications. Beyond basic research, a growing number of pre-clinical applications demonstrate durable repression or activation of disease-relevant genes in models of neurodegenerative disorders, imprinting diseases, cancer, and metabolic disorders such as hypercholesterolemia. These studies highlight both the therapeutic potential of epigenome editing and the importance of understanding chromatin context, downstream signalling, and cell type-dependencies. They also demonstrated potential reversibility of the epigenome editing interrogation. Despite significant progress, key challenges remain, including the reliable prediction of editing outcomes, understanding the mechanistic basis of long-term stability, and development of safe, efficient, and powerful delivery systems. Continued methodological development and systematic comparative studies are expected to further advance epigenome editing toward precision medicine applications.
Keywords:
Epigenome editing
Chromatin regulation
Molecular Epigenetics
DNA methylation
Histone modifications
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.2
Papers:
102
Citations:
1.9K
Organization
No organization information available